Skip to main content
XAIR
NASDAQ Industrial Applications And Services

Board Approves 1-for-20 Reverse Stock Split to Regain Nasdaq Compliance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.41
Mkt Cap
$5.191M
52W Low
$0.335
52W High
$5.7
52W Position info
23% above low
Off High info
93% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

XAIR sits 23% above its 52-week low of $0.335.

Summary

Beyond Air's Board has approved a 1-for-20 reverse stock split, following shareholder approval, as a crucial measure to regain compliance with Nasdaq's minimum bid price rule and avoid delisting.


Key Events · Corporate Governance and Compliance · XAIR

  • Shareholders Approve Reverse Stock Split

    At a special meeting on June 18, 2026, stockholders granted the Board authority to effect a reverse stock split at a ratio between 1-for-2 and 1-for-20.

  • Board Approves 1-for-20 Ratio

    Immediately following shareholder approval, the Board approved a specific reverse stock split ratio of 1-for-20.

  • Aims for Nasdaq Compliance

    The reverse split is intended to raise the per share bid price above $1.00 to comply with Nasdaq Listing Rule 5550(a)(2) by the July 31, 2026 deadline, following prior delisting notices.


Analysis · XAIR · Industrial Applications And Services

Beyond Air's shareholders approved the reverse stock split proposal, and the Board subsequently set the ratio at 1-for-20. This action is a critical step to raise the stock price above $1.00 and meet Nasdaq's listing requirements by the July 31, 2026 deadline, following previous delisting notices and conditional approval. While necessary to maintain listing, reverse splits are generally viewed negatively as they address underlying low stock price issues.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XAIR was trading at $0.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.2M. The 52-week trading range was $0.33 to $5.70. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XAIR - Latest Insights

XAIR
Nov 12, 2026, 9:17 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.00
Real-time Price: $2.00 info
Change: $0 (0%) info
Market Cap: $3.331M info
XAIR
Nov 11, 2026, 5:01 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $2.18
Real-time Price: $2.00 info
Change: -$0.180 (-8%) info
Market Cap: $3.331M info
XAIR
Oct 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.45
Real-time Price: $2.00 info
Change: -$0.4497 (-18%) info
Market Cap: $3.331M info
XAIR
Aug 31, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $5.73
Real-time Price: $2.00 info
Change: -$3.73 (-65%) info
Market Cap: $3.331M info
XAIR
Aug 25, 2026, 7:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.78
Real-time Price: $2.00 info
Change: -$2.78 (-58%) info
Market Cap: $3.331M info